Integral Health Asset Management, LLC Tarsus Pharmaceuticals, Inc. Transaction History
Integral Health Asset Management, LLC
- $850 Million
- Q3 2024
A detailed history of Integral Health Asset Management, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 375,000 shares of TARS stock, worth $19.4 Million. This represents 1.45% of its overall portfolio holdings.
Number of Shares
375,000
Previous 590,000
36.44%
Holding current value
$19.4 Million
Previous $16 Million
23.09%
% of portfolio
1.45%
Previous 1.54%
Shares
3 transactions
Others Institutions Holding TARS
# of Institutions
170Shares Held
43.3MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$177 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$169 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$126 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$117 Million6.32% of portfolio
-
Morgan Stanley New York, NY2.21MShares$114 Million0.01% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.38B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...